Detalhe da pesquisa
1.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet
; 392(10157): 1530-1540, 2018 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266412
2.
Two-vessel peri-scaffold staining and malapposition 12 months after bioresorbable scaffold implantation.
Eur Heart J
; 36(1): 50, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24980491
3.
Local transient myocardial liposomal gene transfer of inducible nitric oxide synthase does not aggravate myocardial function and fibrosis and leads to moderate neovascularization in chronic myocardial ischemia in pigs.
Microcirculation
; 17(1): 69-78, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20141602
4.
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents.
Cardiol Clin
; 38(4): 639-647, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33036724
5.
Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry.
Clin Res Cardiol
; 109(3): 374-384, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31256259
6.
Predictors of bioresorbable scaffold failure in STEMI patients at 3â¯years follow-up.
Int J Cardiol
; 268: 68-74, 2018 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30041805
7.
Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R.
EuroIntervention
; 13(11): 1319-1326, 2017 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28649953
8.
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.
JACC Cardiovasc Interv
; 10(6): 560-568, 2017 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28259663
9.
Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes.
JACC Cardiovasc Interv
; 8(6): 770-777, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25999097
10.
Optical Coherence Tomography Findings in Bioresorbable Vascular Scaffolds Thrombosis.
Circ Cardiovasc Interv
; 8(10): e002518, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26399265
11.
Endothelial dysfunction after stenting and scaffolding of coronary arteries.
Clin Hemorheol Microcirc
; 58(1): 175-81, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25227192
12.
Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure.
Clin Hemorheol Microcirc
; 49(1-4): 271-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22214698
13.
The role of BMS in the drug eluting stent era: is still there any place for them?
Catheter Cardiovasc Interv
; 68(3): 456; author reply 457, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16892446
14.
Recurrent restenosis in a patient with cardiac allograft vasculopathy: after angioplasty and sirolimus, paclitaxel saves the day.
Int J Cardiol
; 113(2): e54-5, 2006 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16757040